Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Getting Back to Basics for Complex Patients

Problems put off are problems exacerbated. In life and health, we need to study and address problems to find solutions. 

Thumbnail

PCI Gets Personal: How to Avoid Bleeds

PCI-related bleeding events potentially carry a host of unwanted consequences.

Thumbnail

Advanced Analytics Make Supply Chain Pros of Cath Lab Teams

Cardinal Health

Good Samaritan Hospital in L.A. looks to its managers to preserve that margin by slashing supply costs without compromising clinical quality.

Thumbnail

[ARTICLE] Building a Protected PCI Program: The Heart Team Approach

Offered in cooperation with Abiomed

High-risk PCI patients have new options at Einstein Healthcare Network in Philadelphia with the Impella 2.5, a miniature heart pump for use in elective and urgent high-risk PCI procedures.

FDA issues Class I recall of Syncardia Freedom driver

The FDA has issued a Class I recall of a select number of SynCardia Systems Total Artificial Heart Freedom driver.

Documentary highlights robotic-assisted PCI

Corindus Vascular Robotics released a documentary on Sept. 16 to promote its CorPath System, the only FDA-cleared device for robotic-assisted PCI.

Thumbnail

[VIDEO] Building a Protected PCI Program: The Heart Team Approach

Offered in cooperation with Abiomed

Building a Protected PCI Program: The Heart Team Approach

Thumbnail

Questions surround dual antiplatelet therapy duration after PCI with drug-eluting stents

Current guidelines in the U.S. recommend patients take dual antiplatelet therapy for at least a year after PCI with drug-eluting stents. The guidelines on the duration of dual antiplatelet therapy may be soon altered, however, based on results of recent studies.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.